ID   ALG3_HUMAN              Reviewed;         438 AA.
AC   Q92685; A8JZZ6; Q9BT71;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   15-MAR-2017, entry version 149.
DE   RecName: Full=Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase;
DE            EC=2.4.1.258;
DE   AltName: Full=Asparagine-linked glycosylation protein 3 homolog;
DE   AltName: Full=Dol-P-Man-dependent alpha(1-3)-mannosyltransferase;
DE   AltName: Full=Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase;
DE   AltName: Full=Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase;
DE   AltName: Full=Not56-like protein;
GN   Name=ALG3; Synonyms=NOT, NOT56L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Kurzik-Dumke U., Kaymer M.;
RT   "Sequence of the human homologue of the Drosophila melanogaster Not56
RT   protein and its expression in various tissues.";
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CHARACTERIZATION, VARIANT CDG1D ASP-118, AND FUNCTION.
RX   PubMed=10581255; DOI=10.1093/emboj/18.23.6816;
RA   Koerner C., Knauer R., Stephani U., Marquardt T., Lehle L.,
RA   von Figura K.;
RT   "Carbohydrate deficient glycoprotein syndrome type IV: deficiency of
RT   dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase.";
RL   EMBO J. 18:6816-6822(1999).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   VARIANT CDG1D GLN-171.
RX   PubMed=15840742; DOI=10.1210/jc.2005-0250;
RA   Sun L., Eklund E.A., Chung W.K., Wang C., Cohen J., Freeze H.H.;
RT   "Congenital disorder of glycosylation Id presenting with
RT   hyperinsulinemic hypoglycemia and islet cell hyperplasia.";
RL   J. Clin. Endocrinol. Metab. 90:4371-4375(2005).
CC   -!- FUNCTION: Adds the first Dol-P-Man derived mannose in an alpha-1,3
CC       linkage to Man5GlcNAc2-PP-Dol. {ECO:0000269|PubMed:10581255}.
CC   -!- CATALYTIC ACTIVITY: Dolichyl beta-D-mannosyl phosphate + D-Man-
CC       alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-alpha-(1->3)-(D-Man-alpha-
CC       (1->6))-D-Man-beta-(1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-
CC       diphosphodolichol = D-Man-alpha-(1->2)-D-Man-alpha-(1->2)-D-Man-
CC       alpha-(1->3)-(D-Man-alpha-(1->3)-D-Man-alpha-(1->6))-D-Man-beta-
CC       (1->4)-D-GlcNAc-beta-(1->4)-D-GlcNAc-diphosphodolichol + dolichyl
CC       phosphate.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- INTERACTION:
CC       O43889-2:CREB3; NbExp=3; IntAct=EBI-2848814, EBI-625022;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92685-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92685-2; Sequence=VSP_042738;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Congenital disorder of glycosylation 1D (CDG1D)
CC       [MIM:601110]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:10581255,
CC       ECO:0000269|PubMed:15840742}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 58 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y09022; CAA70220.1; -; mRNA.
DR   EMBL; AK289361; BAF82050.1; -; mRNA.
DR   EMBL; AC061705; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002839; AAH02839.1; -; mRNA.
DR   EMBL; BC004313; AAH04313.1; -; mRNA.
DR   CCDS; CCDS46967.1; -. [Q92685-2]
DR   CCDS; CCDS46968.1; -. [Q92685-1]
DR   RefSeq; NP_001006942.1; NM_001006941.2. [Q92685-2]
DR   RefSeq; NP_005778.1; NM_005787.5. [Q92685-1]
DR   UniGene; Hs.478481; -.
DR   ProteinModelPortal; Q92685; -.
DR   BioGrid; 115490; 11.
DR   IntAct; Q92685; 5.
DR   STRING; 9606.ENSP00000380793; -.
DR   CAZy; GT58; Glycosyltransferase Family 58.
DR   iPTMnet; Q92685; -.
DR   PhosphoSitePlus; Q92685; -.
DR   BioMuta; ALG3; -.
DR   DMDM; 3024226; -.
DR   EPD; Q92685; -.
DR   MaxQB; Q92685; -.
DR   PaxDb; Q92685; -.
DR   PeptideAtlas; Q92685; -.
DR   PRIDE; Q92685; -.
DR   DNASU; 10195; -.
DR   Ensembl; ENST00000397676; ENSP00000380793; ENSG00000214160. [Q92685-1]
DR   Ensembl; ENST00000445626; ENSP00000402744; ENSG00000214160. [Q92685-2]
DR   GeneID; 10195; -.
DR   KEGG; hsa:10195; -.
DR   UCSC; uc003fne.3; human. [Q92685-1]
DR   CTD; 10195; -.
DR   DisGeNET; 10195; -.
DR   GeneCards; ALG3; -.
DR   GeneReviews; ALG3; -.
DR   HGNC; HGNC:23056; ALG3.
DR   HPA; HPA045103; -.
DR   MalaCards; ALG3; -.
DR   MIM; 601110; phenotype.
DR   MIM; 608750; gene.
DR   neXtProt; NX_Q92685; -.
DR   OpenTargets; ENSG00000214160; -.
DR   Orphanet; 79321; ALG3-CDG.
DR   PharmGKB; PA134897460; -.
DR   eggNOG; KOG2762; Eukaryota.
DR   eggNOG; ENOG410XSN8; LUCA.
DR   GeneTree; ENSGT00390000013904; -.
DR   HOGENOM; HOG000237555; -.
DR   HOVERGEN; HBG002070; -.
DR   InParanoid; Q92685; -.
DR   KO; K03845; -.
DR   OMA; DWKAYMD; -.
DR   OrthoDB; EOG091G0FWS; -.
DR   PhylomeDB; Q92685; -.
DR   TreeFam; TF105870; -.
DR   BRENDA; 2.4.1.258; 2681.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; ALG3; human.
DR   GeneWiki; ALG3; -.
DR   GenomeRNAi; 10195; -.
DR   PRO; PR:Q92685; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000214160; -.
DR   CleanEx; HS_ALG3; -.
DR   ExpressionAtlas; Q92685; baseline and differential.
DR   Genevisible; Q92685; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000033; F:alpha-1,3-mannosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0052925; F:dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome.
DR   GO; GO:0006486; P:protein glycosylation; NAS:UniProtKB.
DR   InterPro; IPR007873; Glycosyltransferase_ALG3.
DR   PANTHER; PTHR12646; PTHR12646; 1.
DR   Pfam; PF05208; ALG3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Disease mutation;
KW   Endoplasmic reticulum; Glycosyltransferase; Membrane; Phosphoprotein;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    438       Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-
FT                                1,3-mannosyltransferase.
FT                                /FTId=PRO_0000080566.
FT   TRANSMEM     41     61       Helical. {ECO:0000255}.
FT   TRANSMEM     95    115       Helical. {ECO:0000255}.
FT   TRANSMEM    123    143       Helical. {ECO:0000255}.
FT   TRANSMEM    149    169       Helical. {ECO:0000255}.
FT   TRANSMEM    172    192       Helical. {ECO:0000255}.
FT   TRANSMEM    203    223       Helical. {ECO:0000255}.
FT   TRANSMEM    231    251       Helical. {ECO:0000255}.
FT   TRANSMEM    289    309       Helical. {ECO:0000255}.
FT   TRANSMEM    332    352       Helical. {ECO:0000255}.
FT   TRANSMEM    356    376       Helical. {ECO:0000255}.
FT   TRANSMEM    407    427       Helical. {ECO:0000255}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     66       MAAGLRKRGRSGSAAQAEGLCKQWLQRAWQERRLLLREPRY
FT                                TLLVAACLCLAEVGITFWVIHRVAY -> MFPAQAKENAGF
FT                                SGCGGD (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042738.
FT   VARIANT     107    107       I -> V (in dbSNP:rs2233463).
FT                                /FTId=VAR_037805.
FT   VARIANT     118    118       G -> D (in CDG1D; dbSNP:rs28940588).
FT                                {ECO:0000269|PubMed:10581255}.
FT                                /FTId=VAR_010306.
FT   VARIANT     171    171       R -> Q (in CDG1D; dbSNP:rs119103236).
FT                                {ECO:0000269|PubMed:15840742}.
FT                                /FTId=VAR_037806.
SQ   SEQUENCE   438 AA;  50126 MW;  687FC8E4A588FD9C CRC64;
     MAAGLRKRGR SGSAAQAEGL CKQWLQRAWQ ERRLLLREPR YTLLVAACLC LAEVGITFWV
     IHRVAYTEID WKAYMAEVEG VINGTYDYTQ LQGDTGPLVY PAGFVYIFMG LYYATSRGTD
     IRMAQNIFAV LYLATLLLVF LIYHQTCKVP PFVFFFMCCA SYRVHSIFVL RLFNDPVAMV
     LLFLSINLLL AQRWGWGCCF FSLAVSVKMN VLLFAPGLLF LLLTQFGFRG ALPKLGICAG
     LQVVLGLPFL LENPSGYLSR SFDLGRQFLF HWTVNWRFLP EALFLHRAFH LALLTAHLTL
     LLLFALCRWH RTGESILSLL RDPSKRKVPP QPLTPNQIVS TLFTSNFIGI CFSRSLHYQF
     YVWYFHTLPY LLWAMPARWL THLLRLLVLG LIELSWNTYP STSCSSAALH ICHAVILLQL
     WLGPQPFPKS TQHSKKAH
//
